Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
R Tang, J Xu, W Wang, Q Meng, C Shao, Y Zhang… - Cell Reports …, 2023 - cell.com
The molecular dynamics of pancreatic ductal adenocarcinoma (PDAC) under chemotherapy
remain incompletely understood. The widespread use of neoadjuvant chemotherapy (NAC) …
remain incompletely understood. The widespread use of neoadjuvant chemotherapy (NAC) …
Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
G Wang, Y Yao, H Huang, J Zhou, C Ni - Frontiers in Oncology, 2023 - frontiersin.org
Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes
and is characterized by abundant infiltrating immune cells within the microenvironment. As …
and is characterized by abundant infiltrating immune cells within the microenvironment. As …
Forward single‐cell sequencing into clinical application: understanding of cancer microenvironment at single‐cell solution
X Liu, CA Powell, X Wang - Clinical and Translational Medicine, 2022 - Wiley Online Library
Single‐cell RNA sequencing (scRNA‐seq) is considered an important approach to
understand the molecular mechanisms of cancer microenvironmental functions and has the …
understand the molecular mechanisms of cancer microenvironmental functions and has the …
[HTML][HTML] Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Breast cancer (BC) is defined by distinct molecular subtypes with different cells of origin. The
transcriptional networks that characterize the subtype-specific tumor-normal lineages are not …
transcriptional networks that characterize the subtype-specific tumor-normal lineages are not …
[HTML][HTML] Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in …
Background In recent years, advancements in cancer treatment have enabled cancer cell
inhibition, leading to improved patient outcomes. However, the side effects of chemotherapy …
inhibition, leading to improved patient outcomes. However, the side effects of chemotherapy …
Neo-peripheral adaptive immune score predicts neoadjuvant chemotherapy for locally advanced breast cancer
H Wang, X Sheng, T Yan, Y Xu, Y Wang, Y Lin… - Breast Cancer Research …, 2023 - Springer
Purpose Whether peripheral immune cell subsets can predict pathological complete
response (pCR) in breast cancer patients remains to be elucidated. We aimed to dissect the …
response (pCR) in breast cancer patients remains to be elucidated. We aimed to dissect the …
[引用][C] Gang Wang1, Yao Yao2, 3, 4, Huanhuan Huang2, 3, 4, Jun Zhou5 and Chao Ni2, 3, 4
G Wang, Y Yao, H Huang, J Zhou, C Ni - 2023 - europepmc.org
Triple-negative breast cancer (TNBC), defined by the absence of estrogen receptor (ER),
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …